According to United Therapeutics's latest financial reports the company's current earnings are โน2.75 Billion. In 2023 the company made an earning of โน114.51 Billion, an increase over its 2022 earnings that were of โน84.40 Billion. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2024 (TTM) | โน124.15 B | 8.42% |
2023 | โน114.51 B | 35.67% |
2022 | โน84.40 B | 60.49% |
2021 | โน52.59 B | -7.53% |
2020 | โน56.87 B | -648.34% |
2019 | -โน10.38 Billion | -115.63% |
2018 | โน66.35 B | -0.73% |
2017 | โน66.84 B | -26.84% |
2016 | โน91.37 B | 1.42% |
2015 | โน90.09 B | 93.3% |
2014 | โน46.60 B | 82.78% |
2013 | โน25.49 B | -35.06% |
2012 | โน39.26 B | 42.34% |
2011 | โน27.58 B | 90.62% |
2010 | โน14.47 B | 432.71% |
2009 | โน2.71 B | -144.9% |
2008 | -โน6.06 Billion | -1218.11% |
2007 | โน0.54 B | -78.26% |
2006 | โน2.48 B | -32.43% |
2005 | โน3.68 B | 224.69% |
2004 | โน1.13 B | -214.61% |
2003 | -โน0.99 Billion | -35.98% |
2002 | -โน1.55 Billion | |
2000 | -โน7 Billion | 132.2% |
1999 | -โน3.02 Billion |